Make ZURZUVAE commercially available in the U.S
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 8 Nov 2023
- Due
- 31 Dec 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“ZURZUVAE approved in the U.S. for post-partum depression (PPD); expected to be commercially available by end of 2023”
What we found
Evidence strength A What the grades mean
The 10-K filed 2024-02-14 and later filings state ZURZUVAE for PPD became commercially available in the U.S. during Q4 2023, within the deadline, though no exact date is given.
-
A Biogen 10-K filed 2024-02-14
“Neuropsychiatry includes ZURZUVAE for PPD, which became commercially available in the U.S. during the fourth quarter of 2023.” ✓ confirmed on the page
-
A Biogen 10-Q filed 2024-04-24
“ZURZUVAE for PPD became commercially available in the U.S. during the fourth quarter of 2023.” ✓ confirmed on the page
Market reaction: the shares moved -4.4% against the S&P 500 over the three sessions around the disclosure (13 Feb 2024 to 16 Feb 2024). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Make
- Deliverable
- ZURZUVAE
- Where
- U.S.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Biogen? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-BIIB-005357 · Corrections policy